AMPLIMMUNE
Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientific founders from Johns Hopkins University have identified several key immunological ligands and receptors. These immunological checkpoint and co-stimulatory molecules are the basis for developing a new class of biological treatments which modulate critical mechanisms in the body's immune system with the aim of bettering the lives of patients suffering from aberrant immunological conditions.
AMPLIMMUNE
Industry:
Biotechnology Health Care Medical
Founded:
2006-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.amplimmune.com
Total Employee:
1001+
Status:
Active
Contact:
3013099800
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
SPF Microsoft Azure DNS Mimecast Level 3 Communications CSC Global DNS
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
InterWest Partners
InterWest Partners investment in Series A - Amplimmune
Wellcome Trust
Wellcome Trust investment in Series A - Amplimmune
Official Site Inspections
http://www.amplimmune.com
- Host name: ec2-54-157-108-158.compute-1.amazonaws.com
- IP address: 54.157.108.158
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
